Acadia Pharmaceuticals Inc Reports Results For The Quarter Ended In September 30: Earnings Summary

Acadia Pharmaceuticals

07/11/2024 15:08

* ACADIA Pharmaceuticals Inc  ACAD.OQ  reported quarterly
adjusted
earnings of 20 cents​​ per share for the quarter ended September
30, higher than the same quarter last year, when the company
reported EPS of -40 cents.  The mean expectation of
twenty analysts for the quarter was for earnings of 14 cents per
share. Wall Street expected results to range from 7 cents to 22
cents per share.
    * Revenue rose 18.3% to $250.40 million from a year ago;
analysts
expected $248.81 million. 
    * ACADIA Pharmaceuticals Inc's reported EPS for the quarter
was 20
cents​.
    * The company reported quarterly net income of $32.77
million.
    * ACADIA Pharmaceuticals Inc shares had risen by 2.7% this
quarter and lost 49.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 6
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for ACADIA
Pharmaceuticals Inc is 26.50 
This summary was machine generated from LSEG data November 7 at
03:08 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.14           0.20           Beat
 Jun. 30 2024      0.18           0.20           Beat
 Mar. 31 2024      0.05           0.10           Beat
 Dec. 31 2023      0.30           0.28           Missed